Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter study

Jordan M. Estroff, Joseph Devlin, Lara Hoteit, Adnan Hassoune, Matthew D. Neal, Joshua B. Brown, Liling Lu, Shannon Kotch, Joshua P. Hazelton, Ashton B. Christian, Eric O. Yeates, Jeffry Nahmias, Lewis E. Jacobson, Jamie Williams, Kevin M. Schuster, Rick O'Connor, Gregory R. Semon, Angela D. Straughn, Daniel Cullinane, Tanya EgodageMichelle Kincaid, Allison Rollins, Richard Amdur, Babak Sarani

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)541-545
Number of pages5
JournalJournal of Trauma and Acute Care Surgery
Volume97
Issue number4
DOIs
StatePublished - Oct 1 2024
Externally publishedYes

ASJC Scopus Subject Areas

  • Surgery
  • Critical Care and Intensive Care Medicine

Keywords

  • DOAC
  • PCC
  • prothrombin complex concentrate
  • reversal

Cite this